{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:44:16Z","timestamp":1762321456367,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.psyneuen.2012.06.012","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T13:04:27Z","timestamp":1343307867000},"page":"341-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The investigation of leptin and hypothalamic neuropeptides role in first attack psychotic male patients: Olanzapine monotherapy"],"prefix":"10.1016","volume":"38","author":[{"given":"Mehmet","family":"Ak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Sezlev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Sutcigil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suleyman","family":"Akarsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuat","family":"Ozgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulin","family":"Yanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.psyneuen.2012.06.012_bib0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm0202-179","article-title":"Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity","volume":"8","author":"Air","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0010","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.psyneuen.2012.06.012_bib0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0893-133X(01)00237-8","article-title":"Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors","volume":"25","author":"Audinot","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.psyneuen.2012.06.012_bib0020","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2337\/diabetes.53.5.1253","article-title":"Triglycerides induce leptin resistance at the blood\u2013brain barrier","volume":"53","author":"Banks","year":"2004","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.psyneuen.2012.06.012_bib0025","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0899-9007(00)00410-X","article-title":"Neuropeptides and obesity","volume":"16","author":"Beck","year":"2000","journal-title":"Nutrition"},{"issue":"20","key":"10.1016\/j.psyneuen.2012.06.012_bib0030","doi-asserted-by":"crossref","first-page":"9048","DOI":"10.1523\/JNEUROSCI.22-20-09048.2002","article-title":"The catabolic action of insulin in the brain is mediated by melanocortins","volume":"22","author":"Benoit","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-200161010-00011","article-title":"Olanzapine: an updated review of its use in the management of schizophrenia","volume":"61","author":"Bhana","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.physbeh.2004.04.021","article-title":"Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption?","volume":"82","author":"Blundell","year":"2004","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.psyneuen.2012.06.012_bib0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brainres.2003.12.004","article-title":"Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice","volume":"999","author":"Chen","year":"2004","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.psyneuen.2012.06.012_bib0055","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.pnpbp.2011.01.010","article-title":"Weight gain and ghrelin level after olanzapine monotherapy","volume":"35","author":"Chen","year":"2011","journal-title":"Progr. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.psyneuen.2012.06.012_bib0060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s002130000504","article-title":"Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat","volume":"152","author":"Clifton","year":"2000","journal-title":"Psychopharmacology (Berlin)"},{"issue":"February","key":"10.1016\/j.psyneuen.2012.06.012_bib0065","article-title":"Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice","author":"De Hert","year":"2011","journal-title":"Eur. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.psyneuen.2012.06.012_bib0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2007.01.015","article-title":"A clinical study of the association of antipsychotics with hyperlipidemia","volume":"92","author":"de Leon","year":"2007","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.psyneuen.2012.06.012_bib0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0149-7634(99)00083-4","article-title":"Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action","volume":"24","author":"De Vry","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.psyneuen.2012.06.012_bib0080","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1176\/appi.ajp.158.10.1719","article-title":"Association of olanzapine-induced weight gain with an increase in body fat","volume":"158","author":"Eder","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.psyneuen.2012.06.012_bib0085","doi-asserted-by":"crossref","first-page":"e20571","DOI":"10.1371\/journal.pone.0020571","article-title":"Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation","volume":"6","author":"Fern\u00f8","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.psyneuen.2012.06.012_bib0095","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/er.2006-0041","article-title":"Emerging therapeutic strategies for obesity","volume":"27","author":"Foster-Schubert","year":"2006","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.psyneuen.2012.06.012_bib0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jn\/134.2.295","article-title":"Energy homeostatis, obesity and eating disorders: recent advances in endocrinology","volume":"134","author":"Gail","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1017\/S1461145700002042","article-title":"The new generation of antipsychotic drugs: how atypical are they?","volume":"3","author":"Goldstein","year":"2000","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1677\/jme.0.0320145","article-title":"Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system","volume":"32","author":"Hoggard","year":"2004","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1749-6632.2002.tb04293.x","article-title":"Leptin signaling, adiposity and energy balance","volume":"967","author":"Jequier","year":"2002","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"1\u20133","key":"10.1016\/j.psyneuen.2012.06.012_bib0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.schres.2007.11.026","article-title":"Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin","volume":"100","author":"Jin","year":"2008","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.psyneuen.2012.06.012_bib0225","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/er.2006-0041","article-title":"Emerging therapeutic strategies for obesity","volume":"27","author":"Karen","year":"2006","journal-title":"Endocrine Reviews"},{"issue":"10","key":"10.1016\/j.psyneuen.2012.06.012_bib0125","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/sj.ijo.0801400","article-title":"Elevated plasma levels of alpha-melanocyte stimulating hormone (alpha-MSH) are correlated with insulin resistance in obese men","volume":"24","author":"Katsuki","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"1\u20133","key":"10.1016\/j.psyneuen.2012.06.012_bib0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejphar.2004.10.015","article-title":"Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat","volume":"505","author":"Kirk","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.psyneuen.2012.06.012_bib0135","first-page":"5","article-title":"Neuro-hormonal control of food intake: basic mechanisms and clinical implications","volume":"56","author":"Konturek","year":"2005","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2008.09.025","article-title":"Weight effects associated with antipsychotics: a comprehensive database analysis","volume":"110","author":"Parsons","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0150","first-page":"137","article-title":"Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol","volume":"26","author":"Purdon","year":"2001","journal-title":"J. Psychiatry Neurosci."},{"issue":"2","key":"10.1016\/j.psyneuen.2012.06.012_bib0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nut.2004.06.021","article-title":"Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation","volume":"21","author":"Ramos","year":"2005","journal-title":"Nutrition"},{"issue":"5","key":"10.1016\/j.psyneuen.2012.06.012_bib0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0031-1280793","article-title":"Body mass index increase, serum leptin, adiponectin, neuropeptide Y and lipid levels during treatment with olanzapine and haloperidol","volume":"44","author":"Raposo","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0165","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment \u2013 pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.psyneuen.2012.06.012_bib0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0175","first-page":"387","article-title":"Insulin in the brain: a hormonal regulator of energy balance","volume":"13","author":"Schwartz","year":"1992","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0180","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1210\/endo.130.6.1597158","article-title":"Inhibition of hypothalamic neuropeptide Y gene expression by insulin","volume":"130","author":"Schwartz","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0185","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1101\/gad.11.5.593","article-title":"Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice","volume":"11","author":"Shutter","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0190","first-page":"298","article-title":"Pharmacogenetics of antipsychotic-induced weight gain","volume":"19","author":"Sengul","year":"2009","journal-title":"Clin. Psychopahrmacol. Issue"},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0195","first-page":"18","article-title":"The relation between IRS-1 Gly972Arg (insulin receptor substrate) gene polymorphism and olanzapine induced weight gain","volume":"11","author":"Sengul","year":"2010","journal-title":"J. Anatolian Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0200","first-page":"297","article-title":"Safety and tolerability: how do newer generation \u201catypical\u201d antipsychotics compare?","volume":"73","author":"Tandon","year":"2002","journal-title":"Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0205","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1210\/endo.138.11.5651","article-title":"Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob\/ob mice","volume":"138","author":"Thornton","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-8993(89)91668-5","article-title":"Regulation of \u03b1-melanocyte stimulating hormone release from superfused slices from rat hypothalamus by seratonin and the interaction of setatonin with the dopaminergic system inhibiting peptide release","volume":"503","author":"Tiligada","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0215","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.npp.1300626","article-title":"Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride","volume":"30","author":"Wagner","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2012.06.012_bib0220","first-page":"59","article-title":"Antipsychotic-induced weight gain: the role of the genetics?","volume":"18","author":"Yazici","year":"2008","journal-title":"Clin. Psychopahrmacol. Issue"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453012002272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453012002272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:40:16Z","timestamp":1759682416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453012002272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0306453012002272"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2012.06.012","relation":{},"ISSN":["0306-4530"],"issn-type":[{"type":"print","value":"0306-4530"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The investigation of leptin and hypothalamic neuropeptides role in first attack psychotic male patients: Olanzapine monotherapy","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2012.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}